Naila Rabbani currently serves as Managing Director of GLOCENTRICA LTD and adjunct professor as well as Head of Proteomics at Qatar University. In addition, Naila holds the position of President Elect at the International Maillard Reaction Society and is the founder of iDiagnostix. Previous roles include Professor of Basic Medical Sciences at Qatar University's College of Medicine and Associate Professor of Experimental Systems Biology at Warwick Systems Biology and the University of Warwick. Naila's research focuses on vascular complications of diabetes, particularly lipoprotein glycation in diabetic atherosclerosis, and previous investigations led to the discovery of a novel form of LDL. Educational qualifications include a BSc and PhD in Biomedical Sciences from the University of Essex and a Postgraduate Certificate in Academic Practice from the University of Warwick.